project id: TCGA-LUSC; case submitter id: TCGA-63-A5MM; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 69; days to birth: -25348; days to death: 456; ethnicity: not reported; gender: female; race: not reported; vital status: Dead; age at diagnosis: 25348; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; icd 10 code: C34.8; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of lung; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of lung; tumor grade: Not Reported; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 230.0; portion submitter id: TCGA-63-A5MM-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 3.0; percent necrosis: 8.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 42.0; percent tumor cells: 50.0; percent tumor nuclei: 75.0;